A bankruptcy judge on Wednesday cleared cancer-drug maker Dendreon Corp. to pursue a sale in case such a deal yields more money for its creditors than a restructuring led by its bondholders.
from WSJ.com: US Business http://ift.tt/1wj3sqI
via IFTTT
from WSJ.com: US Business http://ift.tt/1wj3sqI
via IFTTT
No comments:
Post a Comment